Inhibition of dendritic cell differentiation by fumaric acid esters

被引:95
作者
Zhu, KJ [1 ]
Mrowietz, U [1 ]
机构
[1] Univ Kiel, Dept Dermatol, D-24105 Kiel, Germany
关键词
apoptosis; dendritic cells; fumarate; psoriasis; treatment;
D O I
10.1046/j.1523-1747.2001.01159.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Fumaric acid esters have proved to be effective for the systemic treatment of severe psoriasis vulgaris. These compounds have been shown to induce a Th2-like cytokine secretion pattern in T cells and to reduce keratinocyte proliferation in vitro. Dendritic cells seem to be of major importance as regulatory cells driving the psoriatic tissue reaction. Monocytes or CD34-positive myeloid progenitor cells are precursors of dendritic cells that can be generated in vitro by culture with granulocyte-macrophage colony-stimulating factor and interleukin-1. Using this model the effect of fumaric acid esters on granulocyte-macrophage colony-stimulating factor/interleukin-4-induced differentiation of monocyte-derived dendritic cells was investigated. The results of this study show that dimethylfumarate as well as methylhydrogenfumarate-calcium-salt (0.01-100 mug per ml) concentration-dependently inhibit monocyte-derived dendritic cell differentiation. This was reflected by an inhibition of CD1a, CD40, CD80, CD86, and HLA-DR expression as well as by a reduced capacity of dimethylfumarate-treated monocyte-derived dendritic cells to stimulate lymphocytes in the allogeneic mixed lymphocyte reaction. Other fumaric acid esters showed no effect on monocyte-derived dendritic cell-differentiation. At higher concentrations (30-100 mug per ml) dimethylfumarate, but not methylhydrogenfumarate calcium-salt induced apoptosis in monocyte-derived dendritic cells as measured by expression of Apo 2.7 and DNA fragmentation (TUNEL assay). These data point to a high susceptibility of the monocyte/dendritic cell system to dimethylfumarate and its main metabolite methylhydrogenfumarate. Other fumaric acid esters investigated were without effect. As the effects of fumarates on monocyte-derived dendritic cells observed occur at concentrations 20-fold lower compared with lymphocytes, our data seem to be of relevance in explaining the possible mode of action of these compounds in psoriasis.
引用
收藏
页码:203 / 208
页数:6
相关论文
共 29 条
[1]  
Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
[2]  
2-4
[3]   ANTIPSORIATIC EFFECT OF FUMARIC-ACID DERIVATIVES - RESULTS OF A MULTICENTER DOUBLE-BLIND-STUDY IN 100 PATIENTS [J].
ALTMEYER, PJ ;
MATTHES, U ;
PAWLAK, F ;
HOFFMANN, K ;
FROSCH, PJ ;
RUPPERT, P ;
WASSILEW, SW ;
HORN, T ;
KREYSEL, HW ;
LUTZ, G ;
BARTH, J ;
RIETZSCHEL, I ;
JOSHI, RK .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 30 (06) :977-981
[4]   Influence of monomethylfumarate on monocytic cytokine formation - explanation for adverse and therapeutic effects in psoriasis? [J].
Asadullah, K ;
Schmid, H ;
Friedrich, M ;
Randow, F ;
Volk, HD ;
Sterry, W ;
Docke, WD .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1997, 289 (11) :623-630
[5]   IL-10 is a key cytokine in psoriasis -: Proof of principle by IL-10 therapy:: A new therapeutic approach [J].
Asadullah, K ;
Sterry, W ;
Stephanek, K ;
Jasulaitis, D ;
Leupold, M ;
Audring, H ;
Volk, HD ;
Döcke, WD .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :783-794
[6]   Chimpanzee dendritic cells derived in vitro from blood monocytes and pulsed with antigen elicit specific immune responses in vivo [J].
Barratt-Boyes, SM ;
Kao, H ;
Finn, OJ .
JOURNAL OF IMMUNOTHERAPY, 1998, 21 (02) :142-148
[7]   Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate [J].
deJong, P ;
Bezemer, AC ;
Zomerdijk, TPL ;
vandePouwKraan, T ;
Ottenhoff, THM ;
Nibbering, PH .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (09) :2067-2074
[8]   How can dendritic cells cause autoimmune disease? [J].
Drakesmith, H ;
Chain, B ;
Beverley, P .
IMMUNOLOGY TODAY, 2000, 21 (05) :214-217
[9]   Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells [J].
Genestier, L ;
Paillot, R ;
Fournel, S ;
Ferraro, C ;
Miossec, P ;
Revillard, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (02) :322-328
[10]   CD40 and CD154 in cell-mediated immunity [J].
Grewal, IS ;
Flavell, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :111-135